Clinical Trial Update: AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 study of AN2728 topical ointment (tapinarof) for mild-to-moderate plaque psoriasis. The trial results were posted in March 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• AN2728 topical ointment (tapinarof) (tapinarof)

Snippet

Sponsor: Pfizer | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2017-03-07